1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA MAP1LC3B2 CTRPv2 pan-cancer AAC -0.13 0.0003
mRNA BASP1 CTRPv2 pan-cancer AAC -0.13 0.0003
mRNA COL6A2 CTRPv2 pan-cancer AAC -0.14 0.0003
mRNA C12orf75 CTRPv2 pan-cancer AAC -0.13 0.0003
mRNA CAP2 CTRPv2 pan-cancer AAC -0.15 0.0003
mRNA SLC27A3 CTRPv2 pan-cancer AAC 0.13 0.0003
mRNA FBLN5 CTRPv2 pan-cancer AAC -0.13 0.0003
mRNA TNFRSF21 CTRPv2 pan-cancer AAC 0.14 0.0003
mRNA MYBL1 CTRPv2 pan-cancer AAC -0.13 0.0003
mRNA ACER2 CTRPv2 pan-cancer AAC 0.13 0.0003
Download CSV